US OptionsDetailed Quotes
ISRG241129P560000
- 13.85
- -2.05-12.89%
15min DelayClose Nov 22 16:00 ET
13.94High13.85Low
13.94Open15.90Pre Close15 Volume2 Open Interest560.00Strike Price20.79KTurnover0.00%IV0.31%PremiumNov 29, 2024Expiry Date12.13Intrinsic Value100Multiplier4DDays to Expiry1.72Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma47.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intuitive Surgical Stock Discussion
2. $Rocket Lab (RKLB.US)$ -- A space logistics company specializing in small satellite launches -- enabling efficient & reliable payload delivery to orbit through their Electron rocket and scalable interplanetary missions.
3. $DigitalOcean (DOCN.US)$ -- Set to become the go-...
📊⚡️📊
Gapping up
$NVIDIA (NVDA.US)$ 's shares increased by 1% after receiving a positive adjustment from Bank of America, which raised its earnings forecasts for 2025 and 2026. The financial institution highlighted Nvidia's significant market opportunity, which it now values at over $400 billion.
$Netflix (NFLX.US)$ experienced a 6.3% rise in its stock value after reporting quarterly earnings that surpassed predict...
Goldman Sachs, Morgan Stanley, Citigroup, and other top financial firms are scheduled to report earnings this week.
Investors will also get financial updates from UnitedHealth Group, Johnson & Johnson, and Intuitive Surgical, while Taiwan Semiconductor Manufacturing and Netflix also will issue earnings this week.
Retail sales, housing starts, building permits, and homebuilder confidence are also on tap this week.
Bond markets are closed for t...
Here are some popular ETFs in US!
1. Equity ETFs (Stocks)
a. SPDR S&P 500 ETF (NYSE: SPY) $SPDR S&P 500 ETF (SPY.US)$
Tracks: The S&P 500 Index, which rep...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...
No comment yet